Rossini D, Lonardi S, Antoniotti C, Santini D, et al. Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO. Br J Cancer 2020 Oct 7. pii: 10.1038/s41416-020-01089.
PMID: 33024268